NeuroDex develops blood based diagnostics for neurodegenerative disorders. Additionally, we assist and advance neurological research and development by making our one-of-a-kind platform available for collaborations.
NeuroDex's technology is based on a unique ability to isolate exosomes derived from neurons (neuronal derived exosomes, or NDE's) and analyzing these.
Company Details
- Employees
- 15
- Founded
- -
- Address
- 27 Strathmore Rd, Natick,massachusetts 01760,united States
- in****@****odex.co
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- neurodex.co
- Keywords
- diagnostics, neurodegenerative, alzheimer's, Exosome, biomarkers, ALS, biomarker, CRO, research, exosomes, levy body dementia, dementia, neurodegenerative diseases, neuronal exosomes.
- HQ
- Natick, Massachusetts
Neurodex Questions
Neurodex's website is neurodex.co
Neurodex's LinkedIn profile is https://www.linkedin.com/company/neurodex
Neurodex has
15 employees.
View email and phone details for 15
employees at Neurodex.
Neurodex's industry is
Biotechnology Research
Neurodex's top competitors are
Vesalius Therapeutics,
Alpha Cognition, Inc.,
Neurogene Inc.,
Longboard Pharmaceuticals,
Trace Neuroscience,
Asha Therapeutics,
Inmune Bio Inc.,
Sbh Sciences,
Cerevance,
Ac Immune.
Neurodex's support email address is info@neurodex.co
Neurodex's categories are Biotechnology Research
Neurodex's founding year is 2018
